Neo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases: the CHARISMA randomized multicenter clinical trial

被引：0

作者：

Ninos Ayez

Eric P van der Stok

Hans de Wilt

Sandra A Radema

Richard van Hillegersberg

Rudi M Roumen

Gerard Vreugdenhil

Pieter J Tanis

Cornelis J Punt

Cornelis H Dejong

Rob L Jansen

Henk M Verheul

Koert P de Jong

Geke A Hospers

Joost M Klaase

Marie-Cecile Legdeur

Esther van Meerten

Ferry A Eskens

Nelly van der Meer

Bruno van der Holt

Cornelis Verhoef

Dirk J Grünhagen

机构：

[1] Erasmus MC Cancer Institute,Department of Surgical Oncology

[2] Radboud University,Department of Surgical Oncology

[3] Nijmegen Medical Center,Department of Medical Oncology

[4] Radboud University,Department of Surgery

[5] Nijmegen Medical Center,Department of Surgery

[6] University Medical Center Utrecht,Department of Medical Oncology

[7] Máxima Medical Center,Department of Surgery

[8] Máxima Medical Center,Department of Medical Oncology

[9] Academic Medical Center,Department of Surgery

[10] Academic Medical Center,Department of Medical Oncology

[11] Maastricht University Medical Center,Department of Medical Oncology

[12] Maastricht University Medical Center,Division of Hepato

[13] VU University Medical Center,Pancreato

[14] University Medical Center Groningen,Biliary Surgery and Liver Transplantation, Department of Surgery

[15] University of Groningen,Department of Medical Oncology

[16] University Medical Center Groningen,Department of Surgery

[17] Medisch Spectrum Twente,Department of Internal Medicine

[18] Medisch Spectrum Twente,Department of Medical Oncology

[19] Erasmus MC Cancer Institute,undefined

[20] Clinical Trial Center,undefined

[21] Erasmus MC Cancer Institute,undefined

来源：

BMC Cancer | / 15卷

关键词：

Colorectal liver metastases; Neo-adjuvant chemotherapy; Surgical resection; Clinical risk score;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[31] Survival benefit of neoadjuvant chemotherapy and surgery versus surgery first for resectable colorectal liver metastases: a cohort study
Behrenbruch, Corina
Prabhakaran, Sowmya
Udayasiri, Dilshan
Hollande, Frederic
Michael, Michael
Hayes, Ian
Heriot, Alexander
Knowles, Brett
Thomson, Benjamin
[J]. ANZ JOURNAL OF SURGERY, 2021, 91 (06) : 1196 - 1202
[32] Neoadjuvant chemotherapy versus upfront surgery as the initial treatment for patients with resectable, synchronous colorectal cancer liver metastases
Lee, Jong Min
Han, Yoon Dae
Cho, Min Soo
Hur, Hyuk
Lee, Kang Young
Kim, Nam Kyu
Min, Byung Soh
[J]. JOURNAL OF SURGICAL ONCOLOGY, 2023, 128 (04) : 549 - 559
[33] Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial
Portier, Guillaume
Elias, Dominique
Bouche, Olivier
Rougier, Philippe
Bosset, Jean-Francois
Saric, Jean
Belghiti, Jacques
Piedbois, Pascal
Guimbaud, Rosine
Nordlinger, Bernard
Bugat, Roland
Lazorthes, Franck
Bedenne, Laurent
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (31) : 4976 - 4982
[34] THE OUTCOME OF PREOPERATIVE CHEMOTHERAPY FOLLOWED BY SURGERY OR UPFRONT SURGERY FOR RESECTABLE LIVER METASTASES FROM COLORECTAL CANCER: A SINGLE CENTER EXPERIENCE
Choi, Sang Il
Young, Kim Sun
Yeon, Baek Ji
Kyung, Shim Eun
Mi, Kim Hyun
Yeon, Ku Ji
Jang, Mi Song, I
Chan, Park Sung
Yong, Kim Dae
Hwan, Oh Jae
Duk, Lee Seung
Sung-Sik, Han
Hoon, Kim Seoung
Jae, Park Sang
[J]. ANNALS OF ONCOLOGY, 2014, 25
[35] Perioperative Systemic Therapy vs Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Alone for Resectable Colorectal Peritoneal Metastases A Phase 2 Randomized Clinical Trial
Rovers, Koen P.
Bakkers, Checca
Nienhuijs, Simon W.
Burger, Jacobus W. A.
Creemers, Geert-Jan M.
Thijs, Anna M. J.
Brandt-Kerkhof, Alexandra R. M.
Madsen, Eva V. E.
van Meerten, Esther
Tuynman, Jurriaan B.
Kusters, Miranda
Versteeg, Kathelijn S.
Aalbers, Arend G. J.
Kok, Niels F. M.
Buffart, Tineke E.
Wiezer, Marinus J.
Boerma, Djamila
Los, Maartje
de Reuver, Philip R.
Bremers, Andreas J. A.
Verheul, Henk M. W.
Kruijff, Schelto
de Groot, Derk Jan A.
Witkamp, Arjen J.
van Grevenstein, Wilhelmina M. U.
Koopman, Miriam
Nederend, Joost
Lahaye, Max J.
Kranenburg, Onno
Fijneman, Remond J. A.
van 't Erve, Iris
Snaebjornsson, Petur
Hemmer, Patrick H. J.
Dijkgraaf, Marcel G. W.
Punt, Cornelis J. A.
Tanis, Pieter J.
de Hingh, Ignace H. J. T.
[J]. JAMA SURGERY, 2021, 156 (08) : 710 - 720
[36] Adjuvant radiotherapy, chemotherapy or surgery alone for high-risk histological node negative esophageal squamous cell carcinoma: Protocol for a multicenter prospective randomized controlled trial
Guo, Xufeng
Fang, Wentao
Li, Zhigang
Yu, Zhengtao
Rong, Tiehua
Fu, Jianhua
Han, Yongtao
Tan, Lijie
Chen, Chun
Liu, Shuoyan
Liao, Yongde
Xiao, Gaoming
Wei, Yucheng
Zhu, Chengchu
Li, Hecheng
Luo, Jinhua
Xing, Wenqun
[J]. THORACIC CANCER, 2018, 9 (12) : 1801 - 1806
[37] Chemotherapy and liver transplantation versus chemotherapy alone in patients with definitively unresectable colorectal liver metastases: A prospective multicentric randomized trial (TRANSMET)
Adam, Rene
Piedvache, Celine
Chiche, Laurence
Salame, Ephrem
Scatton, Olivier
Granger, Victoire
Ducreux, Michel Pierre
Cillo, Umberto
Cauchy, Francois
Mabrut, Jean-Yves
Verslype, Chris
Coubeau, Laurent
Hardwigsen, Jean
Boleslawski, Emmanuel
Muscari, Fabrice
Lerut, Jan
Grimaldi, Lamiae
Levi, Francis
Lewin, Maite
Gelli, Maximiliano
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[38] Control arm for surgery alone is needed but difficult to obtain in randomized trials for adjuvant chemotherapy after liver resection for colorectal metastases
Kokudo, Norihiro
Hasegawa, Kiyoshi
Makuuchi, Masatoshi
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (10) : 1299 - 1300
[39] Neoadjuvant Chemotherapy Followed by Surgery Versus Surgery Alone for Colorectal Cancer Meta-analysis of Randomized Controlled Trials
Huang, Lei
Li, Tuan-Jie
Zhang, Jian-Wen
Liu, Sha
Fu, Bin-Sheng
Liu, Wei
[J]. MEDICINE, 2014, 93 (28) : e231
[40] A multicenter, randomized trial of percutaneous coronary intervention versus bypass surgery in high-risk unstable angina patients
Morrison, DA
Sethi, G
Sacks, J
Grover, F
Sedlis, S
Esposito, R
Ramanathan, KB
Weiman, D
Krucoff, M
Duhaylongsod, F
Raya, T
Pett, S
Vernon, S
Birjiniuk, V
Booth, D
Robinson, C
Talley, JD
Antckli, T
Murphy, E
Floten, H
Curcovic, V
Lucke, JC
Lewis, D
Barbiere, C
Henderson, W
[J]. CONTROLLED CLINICAL TRIALS, 1999, 20 (06): : 601 - 619

← 1 2 3 4 5 →